ABO and FUT2 (secretor) genotyping of hemolyzing and nonhemolyzing patients
Patient . | Age . | Sex . | Hemolysis (Y/N) . | Hemolysis grade . | Genotype FUT2 . | Secretor status . | Phenotype ABO, RhD . | Genotype ABO* . |
---|---|---|---|---|---|---|---|---|
1 | 21 | M | Compensated† | 385AA 428GG | S | A pos | A1.01/O.01.02 | |
2 | 54 | F | N | 385AA 428AA | NS | B pos | B.01/B.01 | |
3 | 51 | F | Y | 2 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
4 | 50 | M | N | 385AA 428GG | S | B pos | B.01/O.01.01 | |
5 | 77 | F | N | 385AA 428GG | S | A pos | A1.01/O.01.01 | |
6 | 73 | M | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.02 |
7 | 34 | F | N | 385AA 428AA | NS | A pos | A1.02 /O.01.02 | |
8 | 27 | M | N | 385AA 428GG | S | A pos | A1.01/O.01.01 | |
9 | 39 | F | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
10 | 53 | F | N | 328AA 428GG | S | B pos | B.01/O.01.01 | |
11 | 74 | M | N | 385AA 428AA | NS | A pos | A1.01/O.01.02 | |
12 | 58 | F | Y | 1 | 328AA 428GG | S | AB pos | A1.01/B.01 |
13 | 64 | M | N | 328AA 428AG | S | A pos | A2.01/O.01.01 | |
14 | 70 | M | N | 385AA 428AA | NS | A pos | A2.01/O.01.02 | |
15 | 60 | M | N | 385AA 428GG | S | B pos | B.01/O.01.01 | |
16 | 60 | M | Y | 3 | 385AA 428AA | NS | A pos | A1.01/O.01.01 |
17 | 76 | M | N | 385AA 428AG | S | A pos | A1.01/O.01.02 | |
18 | 48 | F | N | 385AA 428AG | S | A neg | A1.01/A2.01 | |
19 | 72 | F | Y | 2 | 385AA 428AG | S | AB pos | A1.01/B.01 |
20 | 46 | F | Y | 4 | 385AA 428GG | S | A pos | A1.01/O.01.01 |
21 | 54 | M | N | 385AA 428AA | NS | A pos | A2.01/O.01.01 | |
22 | 52 | F | N | 385AA 428AG | S | Apos | A1.01/O.01.01 | |
23 | 29 | F | Y | 1 | 385AT 428AG | NS‡ | B pos | B.01/O.01.01 |
24 | 60 | F | N | 385AA 428AG | S | A neg | A2.01/O.01.01 | |
25 | 43 | M | N | 385AA 428GG | S | A pos | A1.01/O.01.02 | |
26 | 62 | F | N | 385AA 428AG | S | B pos | B.01/O.01.01 | |
27 | 81 | M | Y | 4 | 385AA 428AG | S | AB pos | A1.01/B.01 |
28 | 63 | M | N | 385AA 428AA | NS | A pos | A1.01/O.01.01 | |
29 | 53 | M | Y | 2 | 385AA 428AG | S | B pos | B.01/B.01 |
30 | 28 | F | Y | 1 | 385AA 428AG | S | B pos | B.01/B.01 |
31 | 26 | F | Y | 1 | 385AA 428AA | NS | B pos | B.01/O.01.02 |
32 | 63 | F | Y | 2 | 385AA 428AG | S | B pos | B.01/O.01.02 |
33 | 75 | F | N | 385AA 428AA | NS | A pos | A1.01/O.01.01 | |
34 | 56 | M | N | 385AA 428GG | S | B pos | B.01/O.01.02 | |
35 | 80 | F | Y | 2 | 385AA 428GG | S | A pos | A1.01/O.01.02 |
36 | 11 | M | N | 385AA 428AG | S | B pos | B.01/B.01 | |
37 | 63 | F | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
38 | 19 | F | Y | 1 | 385AA 428AG | S | A1B pos | A1.01/B.01 |
39 | 59 | F | Y | 1 | 385AA 428GG | S | B pos | B.01/O.01.01 |
40 | 63 | M | Y | 4 | 385AA 428AA | NS | A1B pos | A1.01/B.01 |
41 | 82 | F | Y | 4 | 385AA 428AG | S | A1pos | A1.02/O.01.01 |
42 | 59 | F | Y | 4 | 385AA 428AG | S | A1Bpos | A1.01/B.01 |
Patient . | Age . | Sex . | Hemolysis (Y/N) . | Hemolysis grade . | Genotype FUT2 . | Secretor status . | Phenotype ABO, RhD . | Genotype ABO* . |
---|---|---|---|---|---|---|---|---|
1 | 21 | M | Compensated† | 385AA 428GG | S | A pos | A1.01/O.01.02 | |
2 | 54 | F | N | 385AA 428AA | NS | B pos | B.01/B.01 | |
3 | 51 | F | Y | 2 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
4 | 50 | M | N | 385AA 428GG | S | B pos | B.01/O.01.01 | |
5 | 77 | F | N | 385AA 428GG | S | A pos | A1.01/O.01.01 | |
6 | 73 | M | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.02 |
7 | 34 | F | N | 385AA 428AA | NS | A pos | A1.02 /O.01.02 | |
8 | 27 | M | N | 385AA 428GG | S | A pos | A1.01/O.01.01 | |
9 | 39 | F | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
10 | 53 | F | N | 328AA 428GG | S | B pos | B.01/O.01.01 | |
11 | 74 | M | N | 385AA 428AA | NS | A pos | A1.01/O.01.02 | |
12 | 58 | F | Y | 1 | 328AA 428GG | S | AB pos | A1.01/B.01 |
13 | 64 | M | N | 328AA 428AG | S | A pos | A2.01/O.01.01 | |
14 | 70 | M | N | 385AA 428AA | NS | A pos | A2.01/O.01.02 | |
15 | 60 | M | N | 385AA 428GG | S | B pos | B.01/O.01.01 | |
16 | 60 | M | Y | 3 | 385AA 428AA | NS | A pos | A1.01/O.01.01 |
17 | 76 | M | N | 385AA 428AG | S | A pos | A1.01/O.01.02 | |
18 | 48 | F | N | 385AA 428AG | S | A neg | A1.01/A2.01 | |
19 | 72 | F | Y | 2 | 385AA 428AG | S | AB pos | A1.01/B.01 |
20 | 46 | F | Y | 4 | 385AA 428GG | S | A pos | A1.01/O.01.01 |
21 | 54 | M | N | 385AA 428AA | NS | A pos | A2.01/O.01.01 | |
22 | 52 | F | N | 385AA 428AG | S | Apos | A1.01/O.01.01 | |
23 | 29 | F | Y | 1 | 385AT 428AG | NS‡ | B pos | B.01/O.01.01 |
24 | 60 | F | N | 385AA 428AG | S | A neg | A2.01/O.01.01 | |
25 | 43 | M | N | 385AA 428GG | S | A pos | A1.01/O.01.02 | |
26 | 62 | F | N | 385AA 428AG | S | B pos | B.01/O.01.01 | |
27 | 81 | M | Y | 4 | 385AA 428AG | S | AB pos | A1.01/B.01 |
28 | 63 | M | N | 385AA 428AA | NS | A pos | A1.01/O.01.01 | |
29 | 53 | M | Y | 2 | 385AA 428AG | S | B pos | B.01/B.01 |
30 | 28 | F | Y | 1 | 385AA 428AG | S | B pos | B.01/B.01 |
31 | 26 | F | Y | 1 | 385AA 428AA | NS | B pos | B.01/O.01.02 |
32 | 63 | F | Y | 2 | 385AA 428AG | S | B pos | B.01/O.01.02 |
33 | 75 | F | N | 385AA 428AA | NS | A pos | A1.01/O.01.01 | |
34 | 56 | M | N | 385AA 428GG | S | B pos | B.01/O.01.02 | |
35 | 80 | F | Y | 2 | 385AA 428GG | S | A pos | A1.01/O.01.02 |
36 | 11 | M | N | 385AA 428AG | S | B pos | B.01/B.01 | |
37 | 63 | F | Y | 1 | 385AA 428AG | S | A pos | A1.01/O.01.01 |
38 | 19 | F | Y | 1 | 385AA 428AG | S | A1B pos | A1.01/B.01 |
39 | 59 | F | Y | 1 | 385AA 428GG | S | B pos | B.01/O.01.01 |
40 | 63 | M | Y | 4 | 385AA 428AA | NS | A1B pos | A1.01/B.01 |
41 | 82 | F | Y | 4 | 385AA 428AG | S | A1pos | A1.02/O.01.01 |
42 | 59 | F | Y | 4 | 385AA 428AG | S | A1Bpos | A1.01/B.01 |
Only the last 4 patients were phenotyped for A1/A2.
F, female; M, male; N, no; neg, negative; NS = nonsecretor; pos, positive; RhD, rhesus factor; S = secretor; Y, yes. Bold indicates patients that hemolyzed.
ABO allele terminology here is according to the International Society of Blood Transfusion (www.isbt-web.org) and the Blood Group Antigen Facts Book.26
Compensated hemolysis is determined by positive direct antiglobulin test, Hgb drop < 10 g/L, and reticulocytosis.
Likely partial secretor (included in the nonsecretor group because very little ABO substance is expected in body fluids).